| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
JAGX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 29.3K | - | - | |
| Other | 11.9K | - | - | |
| Other | 11.9K | - | - | |
| CFO | 11.9K | - | - | |
| Other | 11.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2017 | Bochnowski James J | Director | Buy | 100,000 | $0.50 | $50,000.00 | +14.3% | |
| Feb 8, 2016 | Bochnowski James J | Director | Buy | 160,000 | $2.50 | $400,000.00 | +48.8% |